Cargando…
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
Hypoxia exists to some degree in most solid tumors due to inadequate oxygen delivery of the abnormal vasculature which cannot meet the demands of the rapidly proliferating cancer cells. The levels of oxygenation within the same tumor are highly variable from one area to another and can change over t...
Autores principales: | Graham, Kaitlin, Unger, Evan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177375/ https://www.ncbi.nlm.nih.gov/pubmed/30323592 http://dx.doi.org/10.2147/IJN.S140462 |
Ejemplares similares
-
Engineering nanoparticles to overcome barriers to immunotherapy
por: Toy, Randall, et al.
Publicado: (2016) -
Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers
por: Lechpammer, Mirna, et al.
Publicado: (2022) -
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
por: Daniel, S. K., et al.
Publicado: (2019) -
Immunotherapy biomarkers 2016: overcoming the barriers
por: Gulley, James L., et al.
Publicado: (2017) -
Overcoming delivery barriers in immunotherapy for glioblastoma
por: Rui, Yuan, et al.
Publicado: (2021)